Telix Prescription drugs Restricted (TLX) Presents at H.C. Wainwright twenty seventh Annual International


Telix Prescription drugs Restricted (NASDAQ:TLX) H.C. Wainwright twenty seventh Annual International Funding Convention September 9, 2025 12:00 PM EDT

Firm Individuals

Christian Behrenbruch – Co-Founder, MD, Group CEO & Government Director

Convention Name Individuals

Robert Burns – H.C. Wainwright & Co, LLC, Analysis Division

Presentation

Robert Burns
Managing Director & Senior Healthcare Analyst

Welcome to our subsequent fireplace chat. I am Robert Burns, Managing Director and Senior Biotech Analyst, H.C. Wainwright. And I’m joined as we speak by Christian Behrenbruch, the CEO of Telix Prescription drugs. Christian, thanks for becoming a member of us as we speak.

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Sure. Thanks for the chance.

Query-and-Reply Session

Robert Burns
H.C. Wainwright & Co, LLC, Analysis Division

So one of many issues that I first needed to start out off with was clearly, Telix has skilled fast development and transformation through the years. So are you able to share a few of the key components which have contributed to the success?

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Effectively, I feel the corporate is simply actually keen about radiopharmaceuticals. I feel one of many distinctive facets in regards to the firm is we do not actually consider in isotope platforms, proper? We expect that whenever you develop a radiopharmaceutical, you need to have a look at the scientific utility that you simply need to clear up.

It is best to take into consideration what pharmacophore achieves your organic goals finest. After which you need to select the appropriate isotope for the job. And so one of many issues that I feel is admittedly particular in regards to the firm, and it is mirrored within the infrastructure that we have constructed over the past — virtually — firm is sort of 10 years outdated, 8 years as a public firm is that agnosticism.

We would like a — we’re very — we’re a pure-play radio pharma firm. We consider that precision drugs is admittedly essential. That is form of one thing that is not



Source link

Related articles

Apple is reportedly planning new iPad Professional and MacBook Professional releases early subsequent yr

Apple reportedly has plans to launch a number of new iPad Execs and a brand new MacBook Professional within the first half of subsequent yr. The corporate is at the moment engaged on 4...

Dividend Bulletins: June 20-26, 2026

This text was written byComply withFerdiS invests in dividend development shares and writes choices to spice up portfolio revenue. He manages DivGro, a portfolio of primarily dividend development shares created in January 2013....

The center of the web

Reddit - The center of the web ...

USDC And Bitcoin Lead $850 Million Change Outflow Wave

Crypto alternate balances noticed a notable withdrawal wave heading into July 1, with USDC and Bitcoin main roughly $850 million in internet outflows from centralized platforms. The transfer provides one other layer to...

SpaceX confirmed traders a handset-like system prototype with AI tech from xAI, a proprietary OS, a Snapdragon chip, and a design slimmer than an...

Featured Podcasts Large Expertise Podcast: OpenAI's Plan To Merge Chat And Brokers — With Greg Brockman The Large Expertise Podcast takes you behind the scenes within the tech world that includes interviews with plugged-in insiders and...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com